$0.7808
-0.0205-2.56%
Last update: Nov 9, 7:57 AM
Phio Pharmaceuticals Corp
PHIONASDAQ
The average analyst price target for Phio Pharmaceuticals is $10.67, 1266.5% above the current price. The one analyst covering it rates it Buy. Targets range from $4 to $14. The latest change came on Jun 5, 2025, when HC Wainwright & Co. assumed coverage of Phio Pharmaceuticals with a Buy rating and a $14 price target.
Price Target Range — 7 Quarters
Analyst Consensus — 1 Analysts
Rating Trend — Last 9 Months
